Doravirine Patent Expiration

Doravirine is Used for treating HIV-1 infection in pediatric patients. It was first introduced by Merck Sharp And Dohme Corp A Sub Of Merck And Co Inc in its drug Pifeltro on Aug 30, 2018.


Doravirine Patents

Given below is the list of patents protecting Doravirine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Pifeltro US8486975 Non-nucleoside reverse transcriptase inhibitors Oct 07, 2031 Msd Merck Co


Coming Soon

Patent Strength Analyzer

Let us know if you're excited!

🤩🥱

Thank you for your response 🥳